genotoxic in the rat liver and isolated hepatocytes, forming 4 To whom correspondence should be addressed persistent DNA adducts in vivo (6, (8) (9) (10) (11) . Tamoxifen forms Email: bkpark@liv.ac.uk similar adducts in murine hepatocytes (8, 12) but they are Tamoxifen is a hepatic genotoxin in rats and mice but a produced at lower concentrations and are less persistent in vivo hepatocarcinogen only in rats. It is not associated with (12) and, perhaps as a consequence, the drug is not hepato-DNA adducts and liver tumours in patients. The proposed carcinogenic in mice (12) . While DNA binding has not been major pathway for its bioactivation in rats involves α-detected in liver biopsies from patients (13) , the occurrence hydroxylation, O-sulphonation and generation of a of adducts in certain leukocyte (14) and endometrial (15) carbocation that reacts with DNA. Rat liver microsomes samples, though such adducts are not always present (16, 17) , catalyse α-hydroxylation at~2-and 4-fold the rate suggests that tamoxifen can be genotoxic in humans. achieved by human and murine liver microsomes, Metabolic activation is a prerequisite for the production of respectively. O-glucuronylation will deactivate α-hydroxy-DNA adducts from tamoxifen (18) . The pathway generally tamoxifen and compete with sulphonation. Rates of considered to predominate in vivo involves α-hydroxylation O-sulphonation of α-hydroxytamoxifen in hepatic cytosol (8, (19) (20) (21) and O-sulphonation to α-sulphate tamoxifen (22, 23) , have been determined by a HPLC assay of substrateleading ultimately to the generation of an electrophilic dependent 3Ј-phosphoadenosine 5Ј-phosphate production.
carbocation (19,24) capable of reacting with DNA ( Figure 1 ).
The rank order of O-glucuronylation in hepatic microsomes
Desmethyltamoxifen, the principal metabolite of the drug in was estimated by HPLC-mass spectrometry. The rate humans (21), appears to undergo an analogous bioactivation of sulphonation of trans-α-hydroxytamoxifen (25 µM) in in rat liver (11). While trans-α-hydroxytamoxifen does react cytosol from adult female Sprague-Dawley rats and CD1 directly with isolated DNA, the synthetic O-sulphonate gives mice was 5.3 ⍨ 0.8 and 3.9 ⍨ 0.5 pmol/min/mg protein a 180-fold greater yield of adducts (22) . When α-sulphate (mean Ϯ SD, n ⍧ 3), respectively. In cytosol fractions from trans-tamoxifen is incubated with DNA, it produces mutagenic women aged 40-65 years, the rate was 1.1 ⍨ 0.4 pmol/ α-(N 2 -deoxyguanosinyl)tamoxifen adducts identical to those min/mg protein (mean ⍨ SD, n ⍧ 6). The K m for trans-α-found in the hepatic DNA of rats treated with tamoxifen (22, 25) . hydroxytamoxifen in rat, mouse and human cytosol was
The involvement of sulphonation in the bioactivation of 84.6 ⍨ 3.8, 81.4 ⍨ 4.6 and 104.3 ⍨ 5.6 µM (mean ⍨ SD, tamoxifen was established by Davis et al. (23) , who found n ⍧ 3), respectively; the corresponding V max values were that formation of DNA adducts from tamoxifen and α-22.4 ⍨ 3.4, 17.1 ⍨ 3.1 and 6.3 ⍨ 1.9 pmol/min/mg protein.
hydroxytamoxifen in isolated hepatocytes was directly proporThese K m were similar to a value obtained by others tional to the concentration of inorganic sulphate in the medium. using purified rat liver hydroxysteroid sulphotransferase
Evidence that α-hydroxytamoxifen is a substrate of rat and a. Turnover of the cis epimer was too slow for accurate human hepatic sulphotransferase (SULT) was obtained by determination of rates. Sulphonation of trans-α-hydroxydemonstrating an enhancement of adduct formation catalysed tamoxifen in human uterine cytosol was undetectable.
by purified and recombinant enzymes (26) (27) (28) . Rat hydroxyThe rank order of O-glucuronylation of trans-α-hydroxysteroid SULTa was approximately three times more active than tamoxifen in liver microsomes was human >> mouse > rat.
human SULT2A1 (28) . Using the same DNA-binding assay, In combination, lower rates of α-hydroxylation and Otrans-α-hydroxytamoxifen was a better substrate for both rat sulphonation and a higher rate of O-glucuronylation in and human enzymes than its epimer (27, 28) . Bacteria and a human liver would protect patients from the formation of mammalian cell line expressing SULTa but none of those tamoxifen-DNA adducts.
expressing a human SULT metabolized trans-α-hydroxytamoxifen to a mutagenic and DNA adduct-forming species Introduction (26, 29) . The rate of sulphonation has been considered to be the
principal determinant of DNA adduct formation from α-1-butene (tamoxifen; Figure 1 ) is an important adjunct therahydroxytamoxifen in the liver (30). However, it may not be Abbreviations: CV, coefficient of variation; LC-MS, liquid chromatographythe primary cause of the rat's particular vulnerability to DNA mass spectrometry; PAP, 3Ј-phosphoadenosine 5Ј-phosphate; PAPS, 3Ј-phosmodification by tamoxifen because there are marked differences phoadenosine 5Ј-phosphosulphate; SULT, sulphotransferase; tamoxifen, transbetween the rates of α-hydroxylation in rodent and human
hepatic microsomes: in the rank order rat ϾϾ mouse Ͼ human in some detail (26) (27) (28) 
Materials and methods
at 260 nm) were collected in a vessel cooled with solid carbon dioxide and Chemicals concentrated~5-fold at 40°C under a stream of nitrogen. This solution was The sodium salts of estrone β-glucuronide, estriol 3-glucuronide, estriol assayed for PAPS and PAP by HPLC (36) and diluted slightly with distilled 17β-glucuronide and estriol 16α-glucuronide and trisodium uridine 5Ј-diphoswater to obtain concentrations of 250 and 2.25 µM (0.9% PAPS), respectively. phoglucuronic acid (UDPGA), sodium 3Ј-phosphoadenosine 5Ј-phosphate It was concentrated a further 2-fold when required. Trans-α-hydroxytamoxifen
a Data are means Ϯ SD (n ϭ 6) for cytosol/microsomes from individual livers of female transplant donors (40-65 years). b Data are means Ϯ SD (n ϭ 3 ) for cytosol/microsomes from a co-homogenate of four livers from either adult female Sprague-Dawley rats or CD1 mice. ND, not determinable (signal-to-noise ratio Ͻ 1:3)
case severe injuries arising from a road traffic accident. The livers were Glucuronyltransferase assay removed and transferred to the laboratory within 30 min of death. They were Substrate (cis-or trans-α-hydroxytamoxifen, final concentration 0-750 µM, portioned, frozen in liquid nitrogen and stored at -80°C. Approval was granted in standard assay trans-α-hydroxytamoxifen at 66 µM) in acetone (5 µl) was by the relevant ethical committees and prior consent was obtained from the incubated in triplicate with hepatic microsomal preparation (final protein donors' relatives. Normal uterine tissue was obtained from a 42-year-old concentration 2.0 mg/ml), UDPGA (2.4 mM), MgCl 2 (20 mM) and 67 mM Caucasian subject undergoing hysterectomy for dismenorrhoea. It was frozen sodium phosphate buffer (pH 7.4) in a final volume of 250 µl in capped 1.5 ml in liquid nitrogen and stored at -80°C.
microcentrifuge tubes in a shaking water bath at 37°C for 45 min. Some of the incubations also contained either Brij 58 surfactant (0.24 mg/ml) or saccharoPreparation of cytosol and microsomes lactone (5 mM). Either the substrate or UDPGA was omitted from control Samples (10 g) of the stored human livers were homogenized individually in incubations. Reactions were initiated by addition of UDPGA (20 µl of 2 vol ice-cold 67 mM potassium phosphate buffer (pH 7.4) containing 0.15 M 30 mM aqueous solution). They were terminated by adding ice-cold methanol potassium chloride. Equal samples of the six human livers were homogenized (150 µl). Estrone β-glucuronide (2 µl of a 10 mM aqueous solution) was together to obtain the preparation used for determination of enzymatic kinetic added immediately afterwards as an internal standard for estimation of the α-constants. The livers removed from either four female Sprague-Dawley rats hydroxytamoxifen glucuronide. The final mixture was kept at 4°C for 2 h. (250 g body wt; Charles River UK, Margate, UK) or four female CD1 mice Precipitated protein was sedimented by centrifugation and the supernatant (40 g; Biomedical Services Unit, University of Liverpool, Liverpool, UK)
analysed by liquid chromatography-mass spectrometry (LC-MS) within 2 h. immediately after the animals had been killed by cervical dislocation were Aliquots (100 µl) were eluted from a Columbus 5-µm C 8 column at room combined and homogenized. The homogenates were centrifuged at 10 000 g temperature with a gradient of acetonitrile (20-40% over 10 min and 40-85% for 20 min and the resulting supernatants at 105 000 g for 60 min. The over 3 min) in 0.1 M ammonium acetate (pH 6.9). The flow rate was 0.9 ml/min. supernatant was decanted and retained as the cytosol fraction. The micro-
The α-hydroxytamoxifen glucuronide (R t 11.7 min) was monitored at m/z 564 somal pellets were resuspended in phosphate buffer, sedimented ([MϩH] ϩ ) and the estrone β-glucuronide (R t 10.1 min) at m/z 464 ([MϩNH 4 ] ϩ ). (105 000 g for 60 min) and resuspended in chloride-free phosphate buffer.
Selected ion chromatogram peak areas were determined using MassLynx 2.0 Cytosol was prepared from a sample (3 g) of human uterine tissue by the software (Micromass UK, Manchester, UK). Linear calibration graphs (r 2 Ͼ method used to obtain hepatic cytosol. All of the subcellular fractions were 0.98) for the estimation of trans-α-hydroxytamoxifen glucuronide were constored at -80°C for no more than 12 weeks before use. Protein in the fractions structed on each day of analysis using dilutions of an aqueous solution of estrone was assayed by the method of Lowry et al. (37) .
β-glucuronide (final concentration 0-100 µM). Thereby, the amount of substrate glucuronide was expressed as nmol equivalents. The limit of determination of Sulphotransferase assay estrone β-glucuronide was taken to be 0.1 µM (CV 8.7%). At 1 µM, the withinEnzymatic sulphonation of α-hydroxytamoxifen was determined by an assay assay CV was 5.8% (n ϭ 6). At a typical assay concentration of 10 µM equivalents of substrate-dependent PAP formation, which is suitable for reactions yielding of trans-α-hydroxytamoxifen glucuronide the CV was 6.4%. chemically unstable sulphates (35) . The HPLC method of Pennings and van Determination of kinetic constants Kempen (36) was used. Substrate (cis-or trans-α-hydroxytamoxifen, final concentration 2.5-400 µM, in the standard assay 25 µM) in acetone (5 µl)
The sulphonation (in rat liver cytosol) and glucuronylation (in human liver microsomes) reactions were optimized for linear turnover of trans-α-hydroxytawas incubated in triplicate with either hepatic or uterine cytosol (final protein moxifen (25 and 66 µM, respectively) in respect of incubation time and protein concentration 3 mg/ml), PAPS (60 µl, final concentration 1.0-200 µM, in the concentration. PAP formation was linear (r 2 Ͼ 0.98) for at least 30 min at a standard assay 100 µM) and 2-mercaptoethanol (8.3 mM) in a final volume protein concentration of 3 mg/ml and up to a protein concentration of 4 mg/ml of 150 µl made up with 0.25 M potassium phosphate buffer (pH 7.0). over 30 min (r 2 Ͼ 0.98). Glucuronide formation was linear (r 2 Ͼ 0.98) for at least Reactions were performed in capped 1.5 ml microcentrifuge tubes (Eppendorf, 60 min at a protein concentration of 2 mg/ml and up to a protein concentration of Cambridge, UK). All preparations were carried out on ice. Reactions were 4 mg/ml over 45 min (r 2 Ͼ 0.98). initiated by addition of purified PAPS (60 µl of a 250 µM aqueous solution), Apparent kinetic constants (K m and V max ) were determined from plots of the incubated for 20 min at 37°C and terminated with 150 µl of ice-cold methanol.
initial rates (1/V) against 1/[S] generated by non-linear least squares analysis Substrate was omitted from control incubations. The precipitated protein was using GraFit 3.01 software (Erithacus Software, Staines, UK). immediately sedimented by centrifugation at 2000 g for 5 min at 4°C. The supernatant was transferred to a glass vial in ice. Aliquots (50 µl) were LC-MS injected onto the HPLC column within 6 h. Authentic PAPS was stable under Positive ion electrospray mass spectra and selected ion monitoring data were these conditions: a 250 µM aqueous solution underwent Ͻ0.8% conversion acquired by LC-MS using a Quattro II tandem quadrupole instrument, fitted to PAP over 18 h at 0°C. Chromatographic analyses were conducted at with an in-line source, as described previously (31) . Cone voltage fragmentation ambient temperature using a Kontron 325 system (Kontron Instruments, Milan, of analytes was achieved at 70 V when the capillary voltage was 3.9 kV and the Italy) linked to an Ultracarb 5-µm C 18 column (250ϫ4.6 mm i.d.) protected source temperature 70°C. Daughter spectra of protonated trans-α-hydroxyby a C 18 guard column. The eluent was water:methanol (80:20 v/v) containing tamoxifen glucuronide were acquired by LC-MS-MS on a Q-Tof time-of-flight 30 mM potassium dihydrogen phosphate and 3 mM tetrabutylammonium instrument fitted with a Z-spray orthogonal interface (Micromass UK). For perchlorate (pH 7.0). The flow rate was 1.0 ml/min. PAP (R t 8.9 min; PAPS daughter scans, the source and desolvation temperatures were 140 and 350°C, R t 15.0 min) was detected at 260 nm with a Kontron Model 332 detector.
respectively, the cone voltage 35 V, the collision energy 20 eV, the collision gas Chromatographic peak areas were determined using a Kontron Data System argon at 0.5ϫ10 -3 mBar and the MS2 scanning range m/z 60-600. 450-PCIP operating v.4.0 software. A linear calibration graph (r 2 ജ 0.99) was Stability of α-hydroxytamoxifen glucuronide constructed for each group of analytical samples using dilutions of a solution of PAP in distilled water (final concentration 0-50 µM). The limit of
The hydrolytic stability of trans-α-hydroxytamoxifen glucuronide formed by determination was taken to be 0.08 µM at a signal-to-noise ratio of 3:1. At human liver microsomes was determined by incubating the conjugate with the typical assay concentration of 1 µM, the within-assay coefficient of 67 mM potassium phosphate buffer (pH 7.4). Glucuronide in the supernatants variation (CV) was 8.6 Ϯ 4.2% (n ϭ 6). The substrate-dependent formation of 10 0.5 ml microsomal incubations was concentrated on a Sep-Pak Plus C 18 of PAP was calculated by subtracting the amount found in incubations from cartridge (Millipore Corp., Milford, MS) pre-conditioned with methanol and water and eluted with methanol. Effluent concentrated by evaporation under which the substrate had been omitted. nitrogen was chromatographed on a Columbus column as described in respect of the glucuronyltransferase assay. Fractions containing the glucuronide were collected, combined, concentrated by evaporation of the acetonitrile under a stream of nitrogen and diluted to 5 ml with phosphate buffer. This solution was then incubated at 37°C. Aliquots (100 µl) were removed at intervals over 72 h and assayed for α-hydroxytamoxifen by LC-MS (31) .
Aliquots (150 µl) of supernatant from the incubations containing human liver microsomes were concentrated under a stream of nitrogen to remove methanol and incubated with beef liver β-glucuronidase (100 U) in 0.5 ml of 0.1 M sodium acetate buffer (pH 5.0) at 37°C for 6 h. Saccharolactone (4 mM) was included in some of the mixtures to inhibit the β-glucuronidase. The enzymic incubations (100 µl) were analysed by LC-MS.
Results

Sulphonation of α-hydroxytamoxifen
Trans-α-hydroxytamoxifen was a substrate of the SULT(s) in rat, mouse and human hepatic cytosol (Table I) . However, the rate of sulphonation of the cis form was invariably too slow to be measured accurately; at a substrate concentration of 25 µM the signal-to-noise ratio for PAP was 1:3. The initial rates of reaction could be fitted, with r 2 Ͼ 0.98, to a plot of 1/V against 1/[S] (Figure 2 ) from which apparent kinetic constants were determined (Table II) . Rat and mouse cytosol catalysed much more rapid sulphonation than human but the apparent K m for trans-α-hydroxytamoxifen was essentially unaffected by the source of the enzyme. The reaction was saturable in respect of the PAPS concentration; 100 µM was used. Under standard assay conditions, the apparent K m for PAPS in rat liver cytosol was 79 µM.
The cytosol prepared from a sample of human uterine tissue was devoid of measurable activity against trans-α-hydroxytamoxifen.
Glucuronylation of α-hydroxytamoxifen
From LC-MS analyses, trans-α-hydroxytamoxifen was found to be metabolized to a single glucuronide (R t 11.7 min) by human, mouse and rat liver microsomes in the presence of UDPGA (Figure 3) . It co-chromatographed with the glucuronide excreted in bile by female rats administered trans-α-hydroxytamoxifen i.v. (31) . The conjugate formed in human microsomes yielded unchanged substrate, identified by co-elution with the authentic trans epimer and resolution from the more polar cis epimer, when it was hydrolysed by β-glucuronidase. Hydrolysis was inhibited by saccharolactone. At a cone voltage of 70 V the protonated glucuronide (m/z 564) fragmented principally by loss of the equivalent of glucuronic acid (194 a.m.u.) to give m/z 370; interpreted as the consequence of scission of the α-carbon- (40), the glucuronylation of α-hydroxytamoxifen was less extensive at a surfactant:protein (w/w) 370 (base peak) and m/z 325 (5% relative intensity).
In the absence of an authentic conjugate, as in the present ratio of 0.12 (data not shown). Therefore α-hydroxytamoxifen glucuronide formed metabolically was measured by LC-MS case, glucuronylation can be assayed by the incorporation of radiolabelled glucuronic acid (39). However, not even the as the area of its peak in the mass chromatogram for m/z 564, which was expressed as molar equivalents of estrone β-much more extensive turnover of trans-α-hydroxytamoxifen in human microsomes was sufficient to incorporate a detectable glucuronide using a calibration graph for the authentic conjugate's corresponding m/z 464 ion. This should be regarded quantity of radiolabel from 2 µCi of [ 14 C]UDPGA over 2 h when the substrate and cofactor concentrations were 400 and only as a means of deriving a quantitative ranking of relative a Data are means Ϯ SD (n ϭ 3 ). Livers were obtained from female transplant donors (40-65 years); cytosol prepared from co-homogenate of six livers. b Data are means Ϯ SD (n ϭ 3 ). Livers were obtained from either adult female Sprague-Dawley rats or CD1 mice; cytosol prepared from co-homogenate of four livers. somes were too slow to enable accurate determinations but they were estimated to be ജ50-fold lower. The initial rates of the reaction in human microsomes could be fitted, with r 2 Ͼ 0.99, to a plot of 1/V against 1/[S] ( Figure 5 ) from which apparent kinetic constants were calculated: K m and V max values were 75 µM and 1.3 nmol equivalents/min/mg protein, respectively. Co-incubation with the β-glucuronidase inhibitor saccharolactone had no effect on apparent enzyme activity.
The glucuronide isolated from incubations of trans-α-hydroxytamoxifen with human liver microsomes was essentially stable in an aqueous solution, pH 7.4, for up to 72 h, i.e. it was resistant to spontaneous hydrolysis: after 2 and 72 h, respectively, only 3.7 Ϯ 1.4% and 5.5 Ϯ 1.9% (mean Ϯ SD, n ϭ 6) of the conjugate was hydrolysed to α-hydroxytamoxifen.
Discussion
The ultimate reactive metabolite of tamoxifen is believed to be a carbocation (19, 20, 24) derived from a microsomal α-hydroxyl can be eliminated as water, with formation of the carbocation (19), α-hydroxytamoxifen reacts slowly with isolated DNA (22, 43, 44) . Nevertheless, the greater binding in rather than absolute glucuronyltransferase activities in vitro. A unitary molar equivalence cannot be presumed because rat as against human isolated hepatocytes (8) indicates that at least one additional enzymatic reaction is required to produce analyte response factors under LC-MS conditions can be highly sensitive to chemical structure (41) . Thus the response factors most of the genotoxic metabolite generated by the former. The dependence of binding in rat hepatocytes on exogenous (units of ion current peak area/nmol) of estriol 3-glucuronide, estriol 16α-glucuronide and estriol 17β-glucuronide under the sulphate (23) and the greatly enhanced reactivity of synthetic α-sulphate tamoxifen, which produces adducts identical to conditions used during the present work were 170 Ϯ 34, 452 Ϯ 51 and 478 Ϯ 23 (mean Ϯ SD, n ϭ 6), respectively. those formed in vivo (22) , implicates the sulphate as the principal source of this metabolite. Human liver microsomes glucuronylated trans-α-hydroxytamoxifen much more rapidly than either rat or mouse
The potential of SULTs to regulate DNA binding of α-hydroxytamoxifen was confirmed by the greater activity of rat microsomes (Table I) . The rates achieved with the rat micro-hydroxysteroid SULTa against an equivalent human enzyme regarded as one of three processes, namely the rendering of either a parent compound or a pro-reactive metabolite (28) . However, the assay employed depends upon SULTmediated binding rather than measurement of a product of the incapable of (further) activation (46) and deactivation of a reactive intermediate (47) . Since α-hydroxytamoxifen comenzymatic reaction and thereby will be influenced by competing reactions and especially the rapid hydrolysis of α-sulphate bines spontaneously with DNA, glucuronylation would not only prevent further bioactivation through O-sulphonation but tamoxifen (22, 24) . Indeed, synthetic α-sulphate cis-tamoxifen is thought to give a (9-fold) greater yield of adducts than its also deactivate the metabolite. The present findings indicate that the inter-species variation in DNA binding might arise trans isomer in vitro because it has a longer half-life in aqueous solution (22) . Notwithstanding this consideration, the apparent partly from an opposite ranking of the extent to which α-hydroxytamoxifen is glucuronylated. This could be important K m values for SULT activity in rat, mouse and human cytosol, namely 84.6, 81.4 and 104.3 µM, respectively, were similar if bioactivation in human liver is limited significantly by the low activity of hydroxysteroid SULT toward α-hydroxytamoxifen to a value (72 Ϯ 29 µM) obtained using purified rat liver hydroxysteroid SULTa and the DNA-binding assay (27) . Hypo- (26, 28) , in which case the intrinsic reactivity of the alcohol (22, 43, 44) may represent the principal pathway to the DNAthetically, any assay is compromised by the fact that the relatively long-lived carbocation derived from α-sulphate binding carbocation. A similar deduction applies to the human endometrium: measurable DNA binding occurs in vivo (15) tamoxifen undergoes isomerization to yield, after hydration, a mixture of cis-and trans-α-hydroxytamoxifen (24) , which notwithstanding that O-sulphonation of α-hydroxytamoxifen by uterine cytosol was below the limit of detection. Glucurcould result in a recycling of the alcohol (Figure 1) . Conversion of trans-to cis-α-hydroxytamoxifen is catalysed by rat liver onylation would also break the recycling of α-hydroxytamoxifen ( Figure 1 ) via either hydrolysis of its sulphonate or SULT (27) . Formation of the cis epimer might effect DNA binding because it is a poorer substrate for rat and human hydration of its carbocation (19, 24) . It remains the case that a higher rate of tamoxifen α-liver SULT (27, 28) ; binding is approximately one-tenth that achieved with trans-α-hydroxytamoxifen. The presently hydroxylation in rodent hepatocytes (8, 31 ) might be the principal as well as the primary metabolic determinant of their reported stereoselectivity of sulphonation in hepatic cytosol conforms with these earlier findings. It also provides an greater DNA adduction: α-hydroxytamoxifen is metabolized to a reactive intermediate in rat, mouse and human explanation for an estimate that trans-α-hydroxytamoxifen administered to female rats produces~50-fold higher levels of hepatocytes in vitro but only the rodent hepatocytes form a DNA-binding product from tamoxifen (8) . However, if the hepatic DNA adducts than the cis isomer (42) .
The α-hydroxytamoxifen SULT activities were determined variance in O-glucuronylation operates in the intact cell, it will reinforce human hepatocyte protection from reactive with rigorously purified PAPS (0.9% PAPS as PAP) because the commercial product contains substantial, if variable, tamoxifen metabolites afforded by an intrinsic deficiency of bioactivation and make the rat even more susceptible to adduct amounts of PAP, a competitive inhibitor (34) . Nevertheless, the values of K m and V max were not significantly different formation. It is important to note that prolonged exposure to tamoxifen might alter the balance of activation and deactivawhen a relatively pure batch of this product, containing only 8% PAPS as PAP, was used as cofactor (data not shown).
tion: in female rats, tamoxifen increases the expression of certain CYP450 and at least one hepatic glucuronyltransferase Matsui et al. (45) , using PAPS which was from 80 to Ͼ98% pure, also found that hydroxysteroid SULT activities are not without affecting the level of hydroxysteroid SULT mRNA (48) . critically dependent upon the purity of the PAPS.
The proposition that the species-dependent formation of The current model of tamoxifen hepatic genotoxicity (19,49) identifies two reactions, α-hydroxylation and O-sulphonation, DNA adducts from α-hydroxytamoxifen might be determined principally by O-sulphonation (23, 30 ) is supported by the 3-as potentially crucial determinants of bioactivation. To these may be added O-glucuronylation. From this mechanistic underfold greater specific activity of rat hepatic hydroxysteroid SULTa versus human hydroxysteroid SULT2A1 (28) . The data standing, the present and previous (31) studies predict low levels of DNA adduction in human liver and, by implication, reported here establish for the first time that the rank order of formation of hepatic tamoxifen-DNA adducts in vivo, namely a low risk of liver tumours in patients. When the standard techniques for measuring hepatic DNA damage in rodents rat Ͼ mouse ϾϾ human (9, 12, 13) , conforms with that of the total cytosolic SULT activity against α-hydroxytamoxifen (rat were applied to a small sample of patients, no tamoxifenspecific adducts could be detected (13) . ജ mouse Ͼ humans). In particular, we have shown that the intermediate, strain-dependent level of DNA binding in murine liver (approximately one-tenth of that in rats after 4 days) (12) 
